Pan Zheng
University of Maryland, Baltimore(US)Army Medical University(CN)Harbin Engineering University(CN)Chinese Academy of Sciences(CN)Regenex Pharmaceuticals (China)(CN)Changchun Institute of Applied Chemistry(CN)First Affiliated Hospital of Jiangxi Medical College(CN)Oncoceutics (United States)(US)Southwest Hospital(CN)Jiangsu Hengrui Medicine (China)(CN)Fourth People's Hospital of Taiyuan(CN)State Key Laboratory of Luminescent Materials and DevicesState Key Laboratory of Rare Earth Resources UtilizationSichuan University of Science and Engineering(CN)Hubei University of Technology(CN)South China University of Technology(CN)Guangzhou Medical University(CN)Tsinghua University(CN)
Publications by Year
Research Areas
Immunotherapy and Immune Responses, T-cell and B-cell Immunology, Immune Cell Function and Interaction, Cancer Immunotherapy and Biomarkers, Nanoplatforms for cancer theranostics
Most-Cited Works
- → Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control(2007)3,112 cited
- → CD24 and Siglec-10 Selectively Repress Tissue Damage–Induced Immune Responses(2009)767 cited
- → mTOR Regulation and Therapeutic Rejuvenation of Aging Hematopoietic Stem Cells(2009)677 cited
- → TSC–mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species(2008)668 cited
- → Manganese Oxide Nanomaterials: Synthesis, Properties, and Theranostic Applications(2020)514 cited
- → Targeting HIF1α Eliminates Cancer Stem Cells in Hematological Malignancies(2011)404 cited